English
This article is from Asian Journal of Transfusion Science , volume 5 . Abstract Background:: Antibodies against only about 25–28 blood group antigens are known to cause hemolytic reactions (HTRs), and red cell antibody screening should detect such clinically significant antibodies. An extension of the antibody screening test is the ‘type and screen’ done to detect clinically significant antibodies, omiting the anti-human globulin (AHG) cross-match. Aim:: The aim of this study was to find out if the type and screen procedure is a safe method for pre-transfusion testing when compared to the AHG cross-match currently in use in India. Materials and Methods:: We evaluated data from 45373 patients for whom a total of 61668 units of packed red blood cells (PRBC) were cross-matched in the AHG phase using DiaMed® ID cards. An antibody screen was carried out in all the patients using the DiaMed® ID-DiaCell I+II+III. The AHG cross-match was also carried out for all recipients, irrespective of the result of the antibody screen. The results were compared to see if there were any cases where the antibody screening was negative but the AHG cross-match showed incompatibility. Results:: Not a singl
Sign in with your free account to read, download EPUBs or listen.
Ebook · Type and screen policy in the blood bank: Is AHG cross-match still required? A study at a multispecialty corporate hospital in India. · Pathak, Sangeeta, Chandrashekhar, M., Wankhede, G. R. · Internet Archive